AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
分析失败
The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.
LISA · 延伸对话
与 Lisa 深入探讨这篇报告
基于本报告上下文的延伸分析